 | Genmab Announces that Janssen has been Granted U.S. FDA Approval for DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) for Patients with Newly Diagnosed Light-chain (AL) Amyloidosis
finance.yahoo.com - January 15 at 2:28 PM |
 | HC Wainwright Increases Genmab A/S (NASDAQ:GMAB) Price Target to $49.00
americanbankingnews.com - January 15 at 12:47 PM |
| Genmab A/S (NASDAQ:GMAB) Given Buy Rating at HC Wainwright
americanbankingnews.com - January 15 at 12:47 PM |
| Emergent BioSolutions Sees Its Composite Rating Rise To 97
finance.yahoo.com - January 13 at 2:29 PM |
| Genmab A/S (NASDAQ:GMAB) Hits New 1-Year High at $42.51
americanbankingnews.com - January 13 at 1:44 PM |
| Jefferies Financial Group Research Analysts Reduce Earnings Estimates for Genmab A/S (NASDAQ:GMAB)
americanbankingnews.com - January 11 at 1:40 AM |
| Genmab A/S (NASDAQ:GMAB) Expected to Post Quarterly Sales of $285.45 Million
americanbankingnews.com - January 10 at 4:14 AM |
| Analysts Expect Genmab A/S (NASDAQ:GMAB) Will Announce Earnings of $0.12 Per Share
americanbankingnews.com - January 8 at 3:18 PM |
| Genmab A/S (NASDAQ:GMAB) Hits New 52-Week High on Analyst Upgrade
americanbankingnews.com - January 5 at 10:12 AM |
| Genmab A/S (NASDAQ:GMAB) PT Raised to $46.00
americanbankingnews.com - January 4 at 10:01 AM |
|
| Genmab A/S (NASDAQ:GMAB) Receives Consensus Rating of "Hold" from Analysts
americanbankingnews.com - December 31 at 3:44 AM |
| Genmab A/S (NASDAQ:GMAB) Sets New 12-Month High at $40.80
americanbankingnews.com - December 30 at 11:36 AM |
 | Genmab: An European R&D Behemoth With Long-Term Potential
seekingalpha.com - December 24 at 10:29 PM |
| Dow Jones Rises, Nasdaq Hits New High Amid Stimulus Hopes
finance.yahoo.com - December 17 at 4:30 PM |
 | Genmab A/S: Grant of Restricted Stock Units to Board Members and Employees and Grant of Warrants to Employees in Genmab
bloomberg.com - December 16 at 10:39 PM |
| Is GMAB A Good Stock To Buy Now?
finance.yahoo.com - December 16 at 10:39 PM |
| Intra-Cellular Therapies Getting Closer To Key Technical Benchmark
finance.yahoo.com - December 14 at 2:15 PM |
| Genmab A/S (GMAB) CEO Jan van de Winkel on Q3 2020 Results - Earnings Call Transcript
seekingalpha.com - November 5 at 6:12 AM |
| Genmab A/S EPS beats by DKK1.88, beats on revenue
seekingalpha.com - November 4 at 5:39 PM |
| Genmab Announces Financial Results for the First Nine Months of 2020
finance.yahoo.com - November 4 at 12:38 PM |
 | ADC Therapeutics SA: Genmab and ADC Therapeutics Announce Amended Agreement for Camidanlumab Tesirine (Cami)
finanznachrichten.de - October 30 at 7:33 AM |
| Genmab and ADC Therapeutics Announce Amended Agreement for Camidanlumab Tesirine (Cami)
finance.yahoo.com - October 30 at 7:33 AM |
| Sarepta Therapeutics Clears Key Benchmark, Hitting 80-Plus RS Rating
finance.yahoo.com - October 29 at 3:02 PM |
| J&J's daratumumab extends progression-free survival in first-line multiple myeloma
seekingalpha.com - October 22 at 1:11 PM |
| J&J's daratumumab extends survival in first-line multiple myeloma
seekingalpha.com - October 21 at 7:21 PM |
 | Genmab to Host Capital Markets Day
uk.finance.yahoo.com - October 15 at 11:25 PM |
| Genmab Announces Data to be Presented at SITC 35th Anniversary Annual Meeting
uk.finance.yahoo.com - October 15 at 12:02 AM |
| Genmab Commences Binding Arbitration of Two Matters Under License Agreement with Janssen
finance.yahoo.com - September 22 at 6:10 PM |
| Genmab A/S: Genmab to Present at Morgan Stanley 18th Annual Global Healthcare Conference
bloomberg.com - September 12 at 12:13 AM |
 | Strange: Bullish GMAB Analysts Actually See -2.96% Downside
nasdaq.com - August 24 at 12:29 PM |
|
 | Genmab Announces Plan to Transition Arzerra(R) (ofatumumab) to an Oncology Access Program for Chronic Lymphocytic Leukemia Patients in the U.S.
marketwatch.com - August 22 at 8:03 AM |
| Genmab A/S (GMAB) CEO Jan van de Winkel on Q2 2020 Results - Earnings Call Transcript
seekingalpha.com - August 13 at 1:35 AM |
| Genmab A/S: U.S. FDA Extends Review of sBLA, Submitted by Novartis, for Ofatumumab in Relapsing Multiple Sclerosis
bloomberg.com - August 7 at 12:47 PM |
| J&J's subcutaneous daratumumab on par with IV version in multiple myeloma study
seekingalpha.com - July 31 at 9:07 PM |
| Disentangling the effect of Covid-19 on Genmab A/s's share price
uk.finance.yahoo.com - July 23 at 4:47 PM |
| GMAB Crosses Above Average Analyst Target
www.nasdaq.com - July 23 at 11:46 AM |
| J&J's Darzalex Q2 sales up 16%
seekingalpha.com - July 16 at 9:22 AM |
| Hedge Funds Keep Buying Genmab A/S (GMAB)
finance.yahoo.com - June 26 at 12:48 PM |
| AbbVie in Genmab Cancer Pact That Could Be Worth Over $3 Billion
www.bloomberg.com - June 10 at 7:35 AM |
| AbbVie Signs Broad Collaboration Agreement With Denmark's Genmab - Quick Facts
www.nasdaq.com - June 10 at 7:35 AM |
| AbbVie teams up with Genmab in cancer
seekingalpha.com - June 10 at 7:35 AM |
| Genmab's stock surges after drug development deal with AbbView valued at up to nearly $4 billion
finance.yahoo.com - June 10 at 7:35 AM |
| AbbVie and Genmab Ink $4 Billion Cancer-Treatment Pact
finance.yahoo.com - June 10 at 7:35 AM |
 | BRIEF-Genmab Announces European Marketing Authorization For Subcutaneous Formulation Of Darzalex®
www.reuters.com - June 5 at 12:02 AM |
| Genmab Announces Positive Topline Results in Phase III ANDROMEDA Study of Daratumumab in Light-chain (AL) Amyloidosis
uk.finance.yahoo.com - May 28 at 11:14 PM |
| BRIEF-Tavotek Biotherapeutics Enters Into Research Agreement With Genmab A/S To Develop Bispecific Antibodies
www.reuters.com - May 25 at 7:39 PM |
| Genmab's Shares March Higher, Can It Continue?
finance.yahoo.com - May 20 at 9:06 AM |
| Genmab Reaches Analyst Target Price
www.nasdaq.com - May 19 at 1:04 PM |
 | Genmab Announces Data to be Presented at the EHA25 Virtual Congress
www.benzinga.com - May 14 at 12:00 PM |
| GMAB Genmab A/S ADS
www.nasdaq.com - May 7 at 6:50 PM |
